WINSTON-SALEM, N.C. -- (BUSINESS WIRE) -- Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today announced it will report financial results for the second quarter of 2014 on Wednesday, August 6, 2014, before the U.S. financial markets open.
Management will discuss the company’s second quarter financial results, provide a business update, and discuss expectations for the future via conference call at 8:30 a.m. Eastern Daylight Time on Wednesday, August 6, 2014. The conference call may be accessed by dialing 877.703.6107 for domestic participants and 857.244.7306 for international callers (the passcode for the call is 10713062).
A live audio webcast of the conference call will be accessible from the Investor Relations page of Targacept’s website, www.targacept.com. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of the webcast will also be available for replay through the Investor Calendar section of the Investor Relations page of Targacept’s website for at least two weeks following the call.
Targacept is dedicated to building health and restoring independence for patients. For more information, please visit www.targacept.com.